{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:52:05Z","timestamp":1790070725677,"version":"4.0.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","award":["R01844"],"award-info":[{"award-number":["R01844"]}],"id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203216","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:43:51Z","timestamp":1537278231000},"page":"e0203216","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy"],"prefix":"10.1371","volume":"13","author":[{"given":"Abhijit Ricky","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0831-4760","authenticated-orcid":true,"given":"Iain A.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-1112","authenticated-orcid":true,"given":"Brian W.","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","article-title":"Lysosomal storage disorders: A practical guide","author":"A Mehta","DOI":"10.1002\/9781118514672"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"LA Clarke","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/B978-0-444-59565-2.00042-3","article-title":"Mucopolysaccharidoses and mucolipidoses","volume":"113","author":"JE Wraith","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment","volume":"33","author":"R Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"KI Berger","year":"2013","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"MS Muhlebach","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"JE Wraith","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"JE Wraith","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"J Muenzer","year":"2011","journal-title":"Genet Med"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2014.08.012","article-title":"Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial","volume":"114","author":"CJ Hendriksz","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"CJ Hendriksz","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"LA Clarke","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"P Harmatz","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"13","key":"ref14","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"M Aldenhoven","year":"2015","journal-title":"Blood"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0003489414550154","article-title":"Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I","volume":"124","author":"P Arn","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9592.2012.03897.x","article-title":"Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management","volume":"22","author":"K Kirkpatrick","year":"2012","journal-title":"Pediatric Anesthesia"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijporl.2005.01.017","article-title":"Otorhinolaryngological manifestations of the mucopolysaccharidoses","volume":"69","author":"MA Simmons","year":"2005","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ppul.22629","article-title":"Bronchoscopy and airway management in patients with mucopolysaccharidoses (MPS)","volume":"48","author":"MS Muhlebach","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"CM Simonaro","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"K Ohmi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1371\/journal.pone.0002296","article-title":"Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice","volume":"3","author":"J Ausseil","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"LD Archer","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-015-0255-4","article-title":"Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome","volume":"10","author":"AR Pal","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: Management and Treatment Guidelines","volume":"123","author":"J Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: a clinical review and guide to management","volume":"72","author":"JE Wraith","year":"1995","journal-title":"Arch Dis Child"},{"key":"ref26","article-title":"Hematoxylin and eosin staining of tissue and cell sections","volume":"2008","author":"AH Fischer","year":"2008","journal-title":"CSH Protocols"},{"issue":"43","key":"ref27","doi-asserted-by":"crossref","first-page":"37515","DOI":"10.1074\/jbc.M111.287474","article-title":"Mucopolysaccharidosis Type I, Unique Structure of Accumulated Heparan Sulfate and Increased N-Sulfotransferase Activity in Mice Lacking -L-iduronidase","volume":"286","author":"RJ Holley","year":"2011","journal-title":"J Biol Chem"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/mt.2013.141","article-title":"Myeloid\/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease","volume":"21","author":"A Sergijenko","year":"2013","journal-title":"Mol Ther"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1369\/jhc.4A6253.2004","article-title":"Differential expression of basement membrane components in lymphatic tissues","volume":"52","author":"M Maatta","year":"2004","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/mt.2013.29","article-title":"Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation","volume":"21","author":"FL Wilkinson","year":"2013","journal-title":"Mol Ther"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"FL Wilkinson","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/mt.2012.82","article-title":"Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice","volume":"20","author":"A Langford-Smith","year":"2012","journal-title":"Mol Ther"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"TD Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"ref34","unstructured":"Standards for Services for Children with Disorders of Sleep Physiology(2009). Working Party on Sleep Physiology and Respiratory Control Disorders in Childhood, Royal College of Paediatrics and Child Health."},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-5876(85)80066-5","article-title":"Pathological and biochemical study in the adenoid of mucopolysaccharidosis II","volume":"10","author":"T Fujitani","year":"1985","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijporl.2014.11.014","article-title":"Adenoids of patients with mucopolysaccharidoses demonstrate typical alterations","volume":"79","author":"A Keilmann","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ijporl.2014.03.021","article-title":"Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway","volume":"78","author":"B G\u00f6n\u00fclda\u015f","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc842","article-title":"Roles of heparan-sulphate glycosaminoglycans in cancer","volume":"2","author":"R Sasisekharan","year":"2002","journal-title":"Nature Reviews Cancer"},{"issue":"36","key":"ref39","doi-asserted-by":"crossref","first-page":"22936","DOI":"10.1074\/jbc.273.36.22936","article-title":"Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity","volume":"273","author":"DA Pye","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1183\/09031936.00047905","article-title":"Differences in proteoglycan deposition in the airways of moderate and severe asthmatics","volume":"29","author":"L Pini","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/ajrccm.160.2.9809040","article-title":"Enhanced proteoglycan deposition in the airway wall of atopic asthmatics","volume":"160","author":"J Huang","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"154812","DOI":"10.1155\/2013\/154812","article-title":"Defects in tendon, ligament, and enthesis in response to genetic alterations in key proteoglycans and glycoproteins: a review","volume":"2013","author":"SC Juneja","year":"2013","journal-title":"Arthritis"},{"issue":"17","key":"ref43","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1074\/jbc.M108285200","article-title":"The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor","volume":"277","author":"E Bengtsson","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2014.09.012","article-title":"Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I","volume":"114","author":"JM Heppner","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1167\/iovs.11-7377","article-title":"Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome)","volume":"52","author":"RD Young","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref46","first-page":"266","article-title":"Scheie\u2019s syndrome: the architecture of corneal collagen and distribution of corneal proteoglycans","volume":"28","author":"AJ Quantock","year":"1993","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1679\/aohc.64.535","article-title":"Chondroitin sulfate proteoglycan at the basal lamina beneath high endothelial cells in human palatine tonsils: a light and electron microscopic study using the cationic colloidal iron method","volume":"64","author":"Y Sunami-Kataoka","year":"2001","journal-title":"Arch Histol Cytol"},{"issue":"20","key":"ref48","doi-asserted-by":"crossref","first-page":"21266","DOI":"10.1074\/jbc.M309782200","article-title":"Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation","volume":"279","author":"M Strazynski","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of Glycosaminoglycan-Mediated Bone and Joint Disease","volume":"172","author":"CM Simonaro","year":"2008","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"ref50","first-page":"1","article-title":"Obstructive sleep apnoea in MPS: A systematic review of pretreatment and posttreatment prevalence and severity","author":"AR Pal","year":"2015","journal-title":"J Inborn Errors Metabolism Screening"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bjorl.2015.09.006","article-title":"The Impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis","volume":"82","author":"AP Dualibib","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fj.05-4682rev","article-title":"Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation","volume":"20","author":"KR Taylor","year":"2006","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/fmb.12.143","article-title":"Bacterial superinfection following lung inflammatory disorders","volume":"8","author":"M Habibzay","year":"2013","journal-title":"Future Microbiol"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"e22447","DOI":"10.1371\/journal.pone.0022447","article-title":"Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VI","volume":"6","author":"E Eliyahu","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"ref55","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.ijporl.2003.08.018","article-title":"Immunology of tonsils and adenoids: everything the ENT surgeon needs to know","volume":"67","author":"P Brandtzaeg","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"CA Hunter","year":"2015","journal-title":"Nature Immunolology"},{"issue":"9\u201310","key":"ref57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/cbir.1998.0304","article-title":"Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures","volume":"22","author":"A Jikko","year":"1998","journal-title":"Cell Biol Int"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/CMR.00014-10","article-title":"The airway epithelium: soldier in the fight against respiratory viruses","volume":"24","author":"M Vareille","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-6-61","article-title":"Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury","volume":"6","author":"B Beck-Schimmer","year":"2005","journal-title":"Respir Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"140937","DOI":"10.1155\/2012\/140937","article-title":"Macrophage-mediated inflammation and disease: a focus on the lung","volume":"2012","author":"E Gwyer Findlay","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/jir467","article-title":"Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection","volume":"204","author":"J Goulding","year":"2011","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:02:48Z","timestamp":1540342968000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203216"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Dardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203216","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]}}}